Option Care Health (NASDAQ:OPCH) Releases FY25 Earnings Guidance

Option Care Health (NASDAQ:OPCH) updated its FY25 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $1.59-1.69 for the period, compared to the consensus estimate of $1.32. The company issued revenue guidance of $5.2-5.4 billion, compared to the consensus revenue estimate of $5.24 billion. Option Care Health also updated its Q4 guidance to $0.42-0.45 EPS.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on OPCH shares. Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and cut their price target for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. Truist Financial lowered their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Barrington Research dropped their price objective on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a report on Thursday, October 31st. Finally, UBS Group initiated coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price for the company. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, Option Care Health presently has an average rating of “Hold” and an average price target of $29.14.

Option Care Health Stock Performance

Shares of OPCH opened at $23.99 on Monday. Option Care Health has a 52-week low of $21.39 and a 52-week high of $34.63. The stock’s 50-day simple moving average is $23.10 and its 200 day simple moving average is $27.69. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock has a market capitalization of $4.08 billion, a price-to-earnings ratio of 20.16, a price-to-earnings-growth ratio of 2.43 and a beta of 1.31.

Insider Transactions at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the firm’s stock in a transaction dated Friday, November 8th. The shares were purchased at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the acquisition, the director now owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 15.18 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 0.64% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.